Together we will beat cancerDonate
Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.
The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It’s now an approved treatment for them in England and Scotland.
Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.
From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.
Focusing on cancer prevention globally is essential; we cannot say we have beaten cancer until we have beaten it everywhere.
A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening
Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.
Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.
Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India ‘eliminate’ cervical cancer.
We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.
New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.